Clinical presentation and diagnosis of uterine sarcoma, including imaging.

[1]  D. Timmerman,et al.  Clinical management of uterine sarcomas. , 2009, The Lancet. Oncology.

[2]  J. Manola,et al.  Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma. , 2009, European journal of cancer.

[3]  J. Eary,et al.  Fluorodeoxyglucose positron emission tomography in leiomyosarcoma: imaging characteristics , 2009, Nuclear medicine communications.

[4]  T. Hirai,et al.  Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas , 2009, European Radiology.

[5]  A. Lopes,et al.  Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma. , 2009, European journal of obstetrics, gynecology, and reproductive biology.

[6]  J. Prat.  FIGO staging for uterine sarcomas , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[7]  K. Podratz,et al.  Endometrial Stromal Sarcoma: Treatment and Patterns of Recurrence , 2008, International Journal of Gynecologic Cancer.

[8]  N. Mitra,et al.  Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis. , 2008, Gynecologic oncology.

[9]  J. Chan,et al.  Endometrial stromal sarcoma: a population-based analysis , 2008, British Journal of Cancer.

[10]  Yong-Man Kim,et al.  Role of PET or PET/CT in the post-therapy surveillance of uterine sarcoma. , 2008, Gynecologic oncology.

[11]  K. Togashi,et al.  The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas , 2007, European Radiology.

[12]  T. Yen,et al.  18F-fluorodeoxyglucose positron emission tomography in uterine carcinosarcoma , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  J. Chan,et al.  Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas , 2008, Cancer.

[14]  I. Timor-Tritsch,et al.  Three and four-dimensional ultrasound in obstetrics and gynecology , 2007, Current opinion in obstetrics & gynecology.

[15]  Frederik De Keyzer,et al.  Extracranial applications of diffusion-weighted magnetic resonance imaging , 2007, European Radiology.

[16]  C. H. Lai,et al.  0749: Prognostic Factors and Adjuvant Therapy in Uterine Carcinosarcoma , 2006, International Journal of Gynecologic Cancer.

[17]  J. Alcázar,et al.  Endometrial volume and vascularity measurements by transvaginal three-dimensional ultrasonography and power Doppler angiography in stimulated and tumoral endometria: intraobserver reproducibility. , 2006, Gynecologic oncology.

[18]  M. Shida,et al.  Whole-body positron emission tomography with F-18 fluorodeoxyglucose for the detection of recurrence in uterine sarcomas , 2005, International Journal of Gynecologic Cancer.

[19]  P. Neven,et al.  Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. , 2005, Gynecologic oncology.

[20]  J. Alcázar,et al.  Endometrial Volume and Vascularity Measurements by Transvaginal 3‐Dimensional Ultrasonography and Power Doppler Angiography in Stimulated and Tumoral Endometria , 2005, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[21]  H. Yoshikawa,et al.  Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings , 2004, Journal of magnetic resonance imaging : JMRI.

[22]  M. Zhan,et al.  Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. , 2004, Gynecologic oncology.

[23]  E. Oliva,et al.  The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital. , 2004, Gynecologic oncology.

[24]  L. Livi,et al.  Uterine sarcoma: twenty-seven years of experience. , 2003, International journal of radiation oncology, biology, physics.

[25]  N. Raine-Fenning,et al.  The reliability of virtual organ computer‐aided analysis (VOCAL) for the semiquantification of ovarian, endometrial and subendometrial perfusion , 2003, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[26]  Chao-Cheng Huang,et al.  Leiomyosarcoma of the uterus: a clinicopathologic study of 21 cases , 2003, Acta obstetricia et gynecologica Scandinavica.

[27]  W. McCluggage,et al.  Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas? , 2002, Journal of clinical pathology.

[28]  R. Reznek,et al.  MR imaging of uterine sarcomas. , 2001, AJR. American journal of roentgenology.

[29]  N. Umesaki,et al.  Positron emission tomography with (18)F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging. , 2001, Gynecologic oncology.

[30]  P. Ellen Grant,et al.  Diffusion-weighted MR imaging of the brain. , 2000, Radiology.

[31]  B. Monk,et al.  Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus , 2000, Cancer.

[32]  A. Kaider,et al.  Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. , 1999, Gynecologic oncology.

[33]  I. Konishi,et al.  Prognostic factors in uterine carcinosarcoma , 1998, Cancer.

[34]  A. Gadducci,et al.  Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study. , 1997, Gynecologic oncology.

[35]  R. Hustinx,et al.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose , 1996, European Journal of Nuclear Medicine.

[36]  R. Kurman,et al.  BLAUSTEIN'S PATHOLOGY OF THE FEMALE GENITAL TRACT , 1995 .

[37]  W. Andersen,et al.  Uterine Smooth‐Muscle Tumors of Uncertain Malignant Potential , 1994, Obstetrics and gynecology.

[38]  J. Berek,et al.  Uterine Sarcoma in Patients Operated on for Presumed Leiomyoma and Rapidly Growing Leiomyoma , 1994, Obstetrics and gynecology.

[39]  E. Yordan,et al.  Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group study , 1993, Cancer.

[40]  C. Tropé,et al.  Leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS) of the uterus. A survey of patients treated in the Norwegian Radium Hospital 1976–1985 , 1992, International Journal of Gynecologic Cancer.

[41]  C. Perez,et al.  Principles and Practice of Gynecologic Oncology , 1992 .

[42]  Z. Petrovich,et al.  Treatment of uterine sarcomas , 1990, Cancer.

[43]  A. Berchuck,et al.  Treatment of Uterine Leiomyosarcoma , 1988, Obstetrics and gynecology.

[44]  P. Grenier,et al.  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. , 1986, Radiology.

[45]  N. Weiss,et al.  The epidemiology of sarcomas of the uterus. , 1986, Journal of the National Cancer Institute.

[46]  L. Gomez,et al.  Uterine leiomyosarcoma. , 1979, American journal of obstetrics and gynecology.

[47]  L. Gray,et al.  Leiomyosarcoma of the uterus , 1972, Cancer.

[48]  K. Markou,et al.  National Comprehensive Cancer Network (NCCN) Head and Neck Cancers NCCN Clinical Practice Guidelines in Oncology . 2010. , 2011 .

[49]  J. Alcázar,et al.  Three-dimensional power Doppler ultrasound scanning for the prediction of endometrial cancer in women with postmenopausal bleeding and thickened endometrium. , 2009, American journal of obstetrics and gynecology.

[50]  C. Livasy,et al.  EGFR expression and HER2/neu overexpression/amplification in endometrial carcinosarcoma. , 2006, Gynecologic oncology.

[51]  Peter N. Burns,et al.  Ultrasound for the Visualization and Quantification of Tumor Microcirculation , 2004, Cancer and Metastasis Reviews.

[52]  Peter Devilee,et al.  Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2003 .

[53]  M. Hatakenaka,et al.  Uterine endometrial stromal sarcoma located in uterine myometrium: MRI appearance , 2000, European Radiology.

[54]  F. Stuart Foster,et al.  High-frequency color flow imaging of the microcirculation , 2000 .

[55]  O. Stål,et al.  Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases. , 1998, Gynecologic oncology.

[56]  R. Kortmann,et al.  Radiotherapy in the treatment of uterine sarcomas. A retrospective analysis of 54 cases. , 1996, Gynecologic and obstetric investigation.

[57]  F. Askin,et al.  Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. , 1990, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[58]  C. Zaloudek,et al.  Mesenchymal Tumors of the Uterus , 1987 .

[59]  P. Disaia,et al.  Clinical Gynecologic Oncology , 1981 .

[60]  D. McMeekin.  Chapter 6 – Sarcoma of the Uterus , 1970 .